4CPS-175 Safe use of levetiracetam at doses higher than the maximum recommended
BackgroundLevetiracetam (LEV) is a second-generation antiepileptic drug used as a unique or adjunctive therapy for treating partial or generalised epilepsy. Its maximum dose according to the summary product is 3000 mg/day. In patients with resistant epilepsy sometimes it is used at doses higher than...
Gespeichert in:
Veröffentlicht in: | European journal of hospital pharmacy. Science and practice 2018-03, Vol.25 (Suppl 1), p.A123-A123 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!